Mascoma Wealth Management LLC
Position in HALO — Halozyme Therapeutics, Inc.
CIK 1695664
HANOVER, NH
Position in HALO
as of Jun 30, 2026
· filed Jul 24, 2026
Position Value
$704
+$704 QoQ
Shares Held
9
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#646
of 664 holders
Holding Since
Mar 2023
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Biotechnology
Healthcare · as of Jun 30, 2026Mascoma Wealth Management LLC holds $19,738 across 8 Biotechnology names. HALO ranks #6 (3.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
14 | $6,954 | |
| 2 | EXEL |
Exelixis, Inc.
|
100 | $5,441 | |
| 3 | FTRE |
Fortrea Holdings Inc.
|
150 | $2,610 | |
| 4 | CRSP |
CRISPR Therapeutics AG
|
40 | $2,181 | |
| 5 | IONS |
Ionis Pharmaceuticals Inc
|
14 | $1,110 | |
| 6 | HALO |
Halozyme Therapeutics, Inc.
This page
|
9 | $704 | |
| 7 | LGND |
Ligand Pharmaceuticals Inc
|
2 | $632 | |
| 8 | INSM |
INSMED Inc
|
1 | $106 |
All Filings in HALO
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $704 | 9 | Shares | Sole | 2026-07-24 | |
| 2023-03-31 | $0 | 0 | Shares | Sole | 2023-05-01 | |
| No filing history on record for this holder in this stock. | ||||||